Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study

Importance Retinal structures may serve as a biomarker for dementia, but longitudinal studies examining this link are lacking. Objective To investigate the association of inner retinal layer thickness with prevalent and incident dementia in a general population of Dutch adults. Design, Setting, and Participants From September 2007 to June 2012, participants from the prospective population-based Rotterdam Study who were 45 years and older and had gradable retinal optical coherence tomography images and at baseline were free from stroke, Parkinson disease, multiple sclerosis, glaucoma, macular degeneration, retinopathy, myopia, hyperopia, and optic disc pathology were included. They were followed up until January 1, 2015, for the onset of dementia. Exposures Inner retinal layer thicknesses (ie, retinal nerve fiber layer [RNFL]) and ganglion cell–inner plexiform layer (GC-IPL) thicknesses measured on optical coherence tomography images. Main Outcomes and Measures Odds ratios and hazard ratios for incident dementia per SD decrease in retinal layer thickness adjusted for age, sex, education, and cardiovascular risk factors. Results Of 5065 individuals eligible for optical coherence tomography scanning, 3289 (64.9%) (mean [SD] age 68.9 [9.9] years, 1879 [57%] women) were included in the analysis. Of these 3289 individuals, 41 (1.2%) already had dementia. Thinner GC-IPL was associated with prevalent dementia (odds ratio per SD decrease in GC-IPL, 1.37 [95% CI, 0.99-1.90]). No association was found of RNFL with prevalent dementia. During 14 674 person-years of follow-up (mean [SD], 4.5 [1.6] years), 86 individuals (2.6%) developed dementia of whom 68 (2.1%) had Alzheimer disease. Thinner RNFL at baseline was associated with an increased risk of developing dementia (hazard ratio per SD decrease in RNFL, 1.44 [95% CI, 1.19-1.75]), which was similar for Alzheimer disease (hazard ratio, 1.43 [95% CI, 1.15-1.78]). No association was found between GC-IPL thickness and incident dementia (hazard ratio, 1.13 [95% CI, 0.90-1.43]). Conclusions and Relevance Thinner RNFL is associated with an increased risk of dementia, including Alzheimer disease, suggesting that retinal neurodegeneration may serve as a preclinical biomarker for dementia.

[1]  Gabriëlle H S Buitendijk,et al.  Retinal neurodegeneration and brain MRI markers: the Rotterdam Study , 2017, Neurobiology of Aging.

[2]  Keith L Black,et al.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.

[3]  Emanuele Trucco,et al.  Lateral thinking – Interocular symmetry and asymmetry in neurovascular patterning, in health and disease , 2017, Progress in Retinal and Eye Research.

[4]  M. Avilés-Trigueros,et al.  Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension , 2017, Front. Neurosci..

[5]  P. Visser,et al.  Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis , 2017, Alzheimer's & dementia.

[6]  Enrico Pellegrini,et al.  The application of retinal fundus camera imaging in dementia: A systematic review , 2016, Alzheimer's & dementia.

[7]  Chunbo Li,et al.  Amyloid Plaques in Retina for Diagnosis in Alzheimer’s Patients: a Meta-Analysis , 2016, Front. Aging Neurosci..

[8]  Kinpui Chan,et al.  Optical Coherence Tomography in the UK Biobank Study – Rapid Automated Analysis of Retinal Thickness for Large Population-Based Studies , 2016, PloS one.

[9]  K. Black,et al.  Ocular indicators of Alzheimer’s: exploring disease in the retina , 2016, Acta Neuropathologica.

[10]  Na Rae Kim,et al.  Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease , 2016, PloS one.

[11]  Louise Terry,et al.  Automated Retinal Layer Segmentation Using Spectral Domain Optical Coherence Tomography: Evaluation of Inter-Session Repeatability and Agreement between Devices , 2016, PloS one.

[12]  Pablo Villoslada,et al.  The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.

[13]  M. Cordeiro,et al.  Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression , 2016, Front. Neurol..

[14]  Nicholas G Strouthidis,et al.  Spectral-Domain Optical Coherence Tomography Imaging in 67 321 Adults: Associations with Macular Thickness in the UK Biobank Study. , 2016, Ophthalmology.

[15]  Milan Sonka,et al.  Automated Segmentability Index for Layer Segmentation of Macular SD-OCT Images , 2016, Translational vision science & technology.

[16]  Francesco Pierelli,et al.  Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis , 2015, PloS one.

[17]  Paloma Sobrado-Calvo,et al.  Comparison of Retinal Nerve Fiber Layer Thinning and Retinal Ganglion Cell Loss After Optic Nerve Transection in Adult Albino Rats. , 2015, Investigative ophthalmology & visual science.

[18]  T. Wong,et al.  Retinal neurodegeneration on optical coherence tomography and cerebral atrophy , 2015, Neuroscience Letters.

[19]  Tien Yin Wong,et al.  Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[20]  Aad van der Lugt,et al.  Patterns of cognitive function in aging: the Rotterdam Study , 2014, European Journal of Epidemiology.

[21]  Brad Fortune,et al.  Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats. , 2014, Investigative ophthalmology & visual science.

[22]  Giovanni Staurenghi,et al.  Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. , 2013, Investigative ophthalmology & visual science.

[23]  A. Wimo,et al.  The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.

[24]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.

[25]  Keith L. Black,et al.  Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.

[26]  O. Franco,et al.  The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.

[27]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[28]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[29]  Daniel L. Farkas,et al.  Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.

[30]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[31]  K. Ashe,et al.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.

[32]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[33]  Alfredo A. Sadun,et al.  Retinal ganglion cell degeneration in Alzheimer's disease , 1989, Brain Research.

[34]  C. Miller,et al.  Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.

[35]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[36]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.